Hospital-Acquired Pneumonia

Pathophysiology, Diagnosis, and Treatment

Alicia N. Kieninger, Pamela A Lipsett

Research output: Contribution to journalArticle

Abstract

Hospital-acquired pneumonia (HAP) is one of the most common causes of nosocomial infection, morbidity, and mortality in hospitalized patients. Many patient- and disease-specific factors contribute to the pathophysiology of HAP, particularly in the surgical population. Risk-factor modification and inpatient prevention strategies can have a significant impact on the incidence of HAP. While the best diagnostic strategy remains a subject of some debate, prompt and appropriate antimicrobial therapy in patients suspected of having HAP has been shown to significantly decrease mortality. Because the pathogens responsible for HAP are frequently more virulent and have greater resistance to commonly used antimicrobials than other pathogens, clinicians must have knowledge of the resistance patterns at their institutions to choose appropriate therapy.

Original languageEnglish (US)
Pages (from-to)439-461
Number of pages23
JournalThe Surgical clinics of North America
Volume89
Issue number2
DOIs
StatePublished - Apr 2009

Fingerprint

Pneumonia
Therapeutics
Mortality
Cross Infection
Inpatients
Morbidity
Incidence
Population

Keywords

  • Diagnosis
  • Epidemiology
  • Nosocomial infection
  • Pathophysiology
  • Pneumonia
  • Ventilator

ASJC Scopus subject areas

  • Surgery

Cite this

Hospital-Acquired Pneumonia : Pathophysiology, Diagnosis, and Treatment. / Kieninger, Alicia N.; Lipsett, Pamela A.

In: The Surgical clinics of North America, Vol. 89, No. 2, 04.2009, p. 439-461.

Research output: Contribution to journalArticle

@article{49a0dce29ff341d9941ab7545d088d4a,
title = "Hospital-Acquired Pneumonia: Pathophysiology, Diagnosis, and Treatment",
abstract = "Hospital-acquired pneumonia (HAP) is one of the most common causes of nosocomial infection, morbidity, and mortality in hospitalized patients. Many patient- and disease-specific factors contribute to the pathophysiology of HAP, particularly in the surgical population. Risk-factor modification and inpatient prevention strategies can have a significant impact on the incidence of HAP. While the best diagnostic strategy remains a subject of some debate, prompt and appropriate antimicrobial therapy in patients suspected of having HAP has been shown to significantly decrease mortality. Because the pathogens responsible for HAP are frequently more virulent and have greater resistance to commonly used antimicrobials than other pathogens, clinicians must have knowledge of the resistance patterns at their institutions to choose appropriate therapy.",
keywords = "Diagnosis, Epidemiology, Nosocomial infection, Pathophysiology, Pneumonia, Ventilator",
author = "Kieninger, {Alicia N.} and Lipsett, {Pamela A}",
year = "2009",
month = "4",
doi = "10.1016/j.suc.2008.11.001",
language = "English (US)",
volume = "89",
pages = "439--461",
journal = "Surgical Clinics of North America",
issn = "0039-6109",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Hospital-Acquired Pneumonia

T2 - Pathophysiology, Diagnosis, and Treatment

AU - Kieninger, Alicia N.

AU - Lipsett, Pamela A

PY - 2009/4

Y1 - 2009/4

N2 - Hospital-acquired pneumonia (HAP) is one of the most common causes of nosocomial infection, morbidity, and mortality in hospitalized patients. Many patient- and disease-specific factors contribute to the pathophysiology of HAP, particularly in the surgical population. Risk-factor modification and inpatient prevention strategies can have a significant impact on the incidence of HAP. While the best diagnostic strategy remains a subject of some debate, prompt and appropriate antimicrobial therapy in patients suspected of having HAP has been shown to significantly decrease mortality. Because the pathogens responsible for HAP are frequently more virulent and have greater resistance to commonly used antimicrobials than other pathogens, clinicians must have knowledge of the resistance patterns at their institutions to choose appropriate therapy.

AB - Hospital-acquired pneumonia (HAP) is one of the most common causes of nosocomial infection, morbidity, and mortality in hospitalized patients. Many patient- and disease-specific factors contribute to the pathophysiology of HAP, particularly in the surgical population. Risk-factor modification and inpatient prevention strategies can have a significant impact on the incidence of HAP. While the best diagnostic strategy remains a subject of some debate, prompt and appropriate antimicrobial therapy in patients suspected of having HAP has been shown to significantly decrease mortality. Because the pathogens responsible for HAP are frequently more virulent and have greater resistance to commonly used antimicrobials than other pathogens, clinicians must have knowledge of the resistance patterns at their institutions to choose appropriate therapy.

KW - Diagnosis

KW - Epidemiology

KW - Nosocomial infection

KW - Pathophysiology

KW - Pneumonia

KW - Ventilator

UR - http://www.scopus.com/inward/record.url?scp=61549095024&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=61549095024&partnerID=8YFLogxK

U2 - 10.1016/j.suc.2008.11.001

DO - 10.1016/j.suc.2008.11.001

M3 - Article

VL - 89

SP - 439

EP - 461

JO - Surgical Clinics of North America

JF - Surgical Clinics of North America

SN - 0039-6109

IS - 2

ER -